• Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies 

      Speletas M., Voulgaridi I., Sarrou S., Dadouli A., Mouchtouri V.A., Nikoulis D.J., Tsakona M., Kyritsi M.A., Peristeri A.-M., Avakian I., Nasika A., Fragkou P.C., Moschopoulos C.D., Zoubouneli S., Onoufriadis I., Anagnostopoulos L., Matziri A., Papadamou G., Theodoridou A., Tsiodras S., Hadjichristodoulou C. (2022)
      The aim of our study was to investigate the immunogenicity of the BNT162b2 vaccination according to the age and medical status of vaccinated individuals. A total of 511 individuals were enrolled (median age: 54.0 years, ...
    • Repeated leftover serosurvey of sars-cov-2 igg antibodies in greece, may to august 2020 

      Bogogiannidou Z., Speletas M., Vontas A., Nikoulis D.J., Dadouli K., Kyritsi M.A., Mouchtouri V.A., Mina P., Anagnostopoulos L., Koureas M., Karavasilis V., Nikou O., Pinaka O., Thomaidis P.C., Kadoglou K., Bedevis K., Spyrou N., Eleftheriou A.A., Papaevangelou V., Gikas A., Vatopoulos A., Ntzani E.E., Prezerakos P., Tsiodras S., Hadjichristodoulou C. (2021)
      A serosurvey of IgG antibodies against SARS-CoV-2 was conducted in Greece between May and August 2020. It was designed as a cross-sectional survey and was repeated at monthly intervals. The leftover sampling methodology ...
    • Understanding covid-19 epidemiology and implications for control: The experience from a greek semi-closed community 

      Kotsiou O.S., Papagiannis D., Fradelos E.C., Perlepe G., Miziou A., Siachpazidou D.S., Gourgoulianis K.I. (2021)
      Background: We aimed to estimate the SARS-CoV-2 antigen and antibody seroprevalence in one of the worst-affected by the pandemic semi-closed communities in Greece, Deskati, and evaluate the sociodemographic and clinical ...